Sanda M G, Beaty T H, Stutzman R E, Childs B, Walsh P C
Brady Urological Institute, School of Public Health, Baltimore, Maryland.
J Urol. 1994 Jul;152(1):115-9. doi: 10.1016/s0022-5347(17)32831-8.
In an effort to provide new insight into the etiology of benign prostatic hyperplasia (BPH), an evaluation of genetic factors was performed. Recognizing that early age of onset is a marker for hereditary disease, we performed a case-control study of men with early onset of significant BPH. Men in the youngest quartile (less than 64 years old) with a large prostate (greater than 37 gm. resected tissue) who underwent surgery for BPH were identified as case probands from 909 consecutive prostatectomies for BPH. Control probands, selected because of the ability to distinguish treatment for benign prostate disease from treatment for malignant prostate disease, were women whose spouses underwent radical prostatectomy during the same interval. Male relatives of men with early onset of BPH had a 66% cumulative lifetime risk of prostatectomy for BPH, compared to a 17% cumulative risk among control relatives (p = 0.001). A 4-fold increase in age-specific risk of prostatectomy for BPH was present among relatives of men who had undergone prostatectomy for BPH (p = 0.0003), while brothers of these affected cases had a 6-fold increase in risk (p = 0.0089) compared to controls. To determine the likelihood that genetic factors account for this familial aggregation of BPH, segregation analysis was done. Although the small sample size prevented rigorous exclusion of nongenetic models, direct comparison of mendelian and nongenetic models showed that mendelian transmission provided the best overall explanation of the observed familial aggregation. The optimal model suggested mendelian dominant inheritance of a gene associated with early age at onset of BPH. These findings identify family history of BPH as a risk factor for clinical BPH and suggest the presence of a predisposing gene in patients with early onset BPH. Evidence of dominant mendelian transmission of this allele provides a framework for genetic studies to characterize this gene and elucidate the development of BPH in general.
为了对良性前列腺增生(BPH)的病因提供新的见解,我们对遗传因素进行了评估。鉴于发病年龄早是遗传性疾病的一个标志,我们对有明显BPH早发的男性进行了一项病例对照研究。在909例连续的BPH前列腺切除术中,将最年轻四分位数(小于64岁)且前列腺体积大(切除组织大于37克)并接受BPH手术的男性确定为病例先证者。由于能够区分良性前列腺疾病和恶性前列腺疾病的治疗,选择配偶在同一时期接受根治性前列腺切除术的女性作为对照先证者。BPH早发男性的男性亲属进行BPH前列腺切除术的累积终身风险为66%,而对照亲属的累积风险为17%(p = 0.001)。接受BPH前列腺切除术男性的亲属中,BPH前列腺切除术的年龄特异性风险增加了4倍(p = 0.0003),而这些受影响病例的兄弟与对照组相比风险增加了6倍(p = 0.0089)。为了确定遗传因素导致BPH家族聚集的可能性,我们进行了分离分析。尽管样本量小妨碍了对非遗传模型的严格排除,但孟德尔模型和非遗传模型的直接比较表明,孟德尔遗传提供了对观察到的家族聚集的最佳总体解释。最佳模型表明与BPH发病年龄早相关的基因呈孟德尔显性遗传。这些发现确定BPH家族史为临床BPH的一个危险因素,并表明早发BPH患者中存在一个易感基因。该等位基因孟德尔显性遗传的证据为遗传研究提供了一个框架,以表征该基因并总体阐明BPH的发展。